Form 4 · Filed May 7, 2026, 08:30 PM UTC
TYRA/Tyra Biosciences, Inc.
Rueb Yuliya — Vice President, Finance (PAO)
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
2 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 5, 2026 | A | other | 8,333 | $0 | — | 43,354 |
| May 5, 2026 | A | other | 28,000 | — | — | 28,000 |
Source: SEC EDGAR raw filing ↗ · Accession 0001193125-26-212111